We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
0.03%
This Fund
S&P 500
This Quarter
Est. Return
+3.41%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.76B
AUM Growth
-$218M
(-11%)
Cap. Flow
-$265M
Cap. Flow
% of AUM
-15.02%
Top 10 Holdings %
Top 10 Hldgs %
22.75%
Holding
203
New
31
Increased
55
Reduced
62
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RingCentral
RNG
|
+$36.8M |
| 2 |
Acadia Healthcare
ACHC
|
+$30.7M |
| 3 |
BILL Holdings
BILL
|
+$20.8M |
| 4 |
Omnicom Group
OMC
|
+$15.9M |
| 5 |
Equinox Gold
EQX
|
+$14.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DNB
Dun & Bradstreet
DNB
|
+$33.6M |
| 2 |
SLB Ltd
SLB
|
+$23.7M |
| 3 |
Match Group
MTCH
|
+$22.9M |
| 4 |
Murphy Oil
MUR
|
+$19.4M |
| 5 |
Lyft
LYFT
|
+$18.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Consumer Discretionary | 17.8% |
| 3 | Healthcare | 16.38% |
| 4 | Industrials | 9.22% |
| 5 | Materials | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Lightspeed Commerce
LSPD
$1.35B
| $4.76M | 0.27% |
406,904
+182,616
| +81% | +$1.88M |
|
102
Leidos
LDOS
$17.3B
| $4.59M | 0.26% |
29,085
-4,748
| -14% | -$702K |
|
103
Quaker Houghton
KWR
$2.92B
| $4.53M | 0.26% |
+40,464
| New | +$4.39M |
|
104
Eastman Chemical
EMN
$8.42B
| $4.47M | 0.25% |
59,896
+32,768
| +121% | +$2.57M |
|
105
BlueLinx
BXC
$706M
| $4.46M | 0.25% |
59,956
+11,728
| +24% | +$820K |
|
106
Affiliated Managers Group
AMG
$9.76B
| $4.41M | 0.25% |
22,398
-3,556
| -14% | -$617K |
|
107
Evertec
EVTC
$1.78B
| $4.16M | 0.24% |
115,478
-175,030
| -60% | -$6.2M |
|
108
N-able
NABL
$940M
| $4.13M | 0.23% |
510,155
-81,078
| -14% | -$605K |
|
109
Pediatrix Medical
MD
$2.2B
| $4.1M | 0.23% |
+285,906
| New | +$3.92M |
|
110
Halozyme
HALO
$12.2B
| $4.05M | 0.23% |
+77,793
| New | +$4.43M |
|
111
Kohl's
KSS
$2.19B
| $4.03M | 0.23% |
475,299
-605,137
| -56% | -$4.65M |
|
112
Ashland
ASH
$3.5B
| $3.84M | 0.22% |
+76,438
| New | +$3.89M |
|
113
Bristow Group
VTOL
$1.36B
| $3.78M | 0.21% |
+114,593
| New | +$3.46M |
|
114
Douglas Dynamics
PLOW
$1.02B
| $3.77M | 0.21% |
128,000
-362,603
| -74% | -$9.54M |
|
115
Tactile Systems Technology
TCMD
$665M
| $3.77M | 0.21% |
371,887
+349,497
| +1,561% | +$3.99M |
|
116
Resources Connection
RGP
$145M
| $3.7M | 0.21% |
688,228
-100,724
| -13% | -$547K |
|
117
DraftKings
DKNG
$11.9B
| $3.64M | 0.21% |
+84,935
| New | +$3.05M |
|
118
nLIGHT
LASR
$3.17B
| $3.25M | 0.18% |
165,269
-705,121
| -81% | -$8.76M |
|
119
ATN International
ATNI
$492M
| $3.14M | 0.18% |
193,258
-19,382
| -9% | -$316K |
|
120
Compass Minerals
CMP
$1.15B
| $3.09M | 0.18% |
153,576
-526,118
| -77% | -$8.5M |
|
|
JAMF
121
DELISTED
Jamf
JAMF
| $3.06M | 0.17% |
+321,384
| New | +$3.45M |
|
122
Opendoor
OPEN
$3.38B
| $2.91M | 0.17% |
+5,638,365
| New | +$4.08M |
|
123
Riskified
RSKD
$716M
| $2.9M | 0.16% |
581,943
-123,831
| -18% | -$592K |
|
124
Vestis
VSTS
$1.88B
| $2.84M | 0.16% |
+496,372
| New | +$3.48M |
|
125
Forrester Research
FORR
$224M
| $2.76M | 0.16% |
278,756
-43,407
| -13% | -$432K |
|
Similar funds
SIG
CAG
ORCP
ET
GC
MIAS
TAL
IIP
Invenomic Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Invenomic Capital Management held 203 positions worth $1.76B, down 11% from $1.98B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Invenomic Capital Management withdrew a net $265M in Q2 2025, closing 55 positions and reducing 62 holdings. Its most notable exit was Dun & Bradstreet, an estimated $33.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Invenomic Capital Management opened a new position in RingCentral worth $40.5M.
- Invenomic Capital Management's largest Q2 2025 buy was RingCentral: 1,427,359 shares worth $40.5M.
- Invenomic Capital Management added most to Acadia Healthcare in Q2 2025, an estimated $30.7M increase.
- Invenomic Capital Management's biggest Q2 2025 reduction was Match Group, cutting an estimated $22.9M.
- Invenomic Capital Management fully exited Dun & Bradstreet in Q2 2025, selling an estimated $33.6M.
- Invenomic Capital Management's ten largest holdings make up 23% of its $1.76B portfolio in Q2 2025.
- Invenomic Capital Management opened 31 new positions and closed 55 in Q2 2025.
- Invenomic Capital Management's portfolio value fell 11% quarter-over-quarter to $1.76B.
Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.